---
title: "CRO 概念股低开，双成药业、未名医药一字跌停"
type: "News"
locale: "zh-CN"
url: "https://longbridge.com/zh-CN/news/237744997.md"
description: "CRO 概念股低开，双成药业、未名医药一字跌停，博济医药、泓博医药、昊帆生物纷纷低开。"
datetime: "2025-04-28T01:30:00.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/237744997.md)
  - [en](https://longbridge.com/en/news/237744997.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/237744997.md)
---

# CRO 概念股低开，双成药业、未名医药一字跌停

CRO 概念股低开，双成药业、未名医药一字跌停，博济医药、泓博医药、昊帆生物纷纷低开。

### 相关股票

- [002581.CN](https://longbridge.com/zh-CN/quote/002581.CN.md)
- [002693.CN](https://longbridge.com/zh-CN/quote/002693.CN.md)
- [301393.CN](https://longbridge.com/zh-CN/quote/301393.CN.md)
- [300404.CN](https://longbridge.com/zh-CN/quote/300404.CN.md)
- [301230.CN](https://longbridge.com/zh-CN/quote/301230.CN.md)

## 相关资讯与研究

- [华东医药子公司皮肤治疗仪 V30 获批上市](https://longbridge.com/zh-CN/news/290681859.md)
- [赛升药业收到注射用甲磺酸萘莫司他药品注册受理通知书](https://longbridge.com/zh-CN/news/290662095.md)
- [287 亿 BD 三连击，中国创新药决定换种活法](https://longbridge.com/zh-CN/news/290419556.md)
- [云南白药拟投资 3.6 亿元建设无锡药业经皮给药技术产业平台项目](https://longbridge.com/zh-CN/news/290676432.md)
- [翰宇药业子公司利那洛肽化学原料药获得上市申请批准](https://longbridge.com/zh-CN/news/290407026.md)